SCN5A Variant E428D
Summary of observed carriers, functional annotations, and structural context for SCN5A E428D. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT3 penetrance
12%
0/10 effective observations
Estimated BrS1 penetrance
11%
1/10 effective observations
Total carriers
0
0 BrS1 · 0 LQT3 · 0 unaffected
Variant features alone are equivalent to phenotyping 1 individuals for Brugada syndrome and 0 individuals for LQT3.
In silico predictors
PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density BrS (%) | Penetrance Density LQT3 (%) |
---|---|---|---|---|---|
NA | NA | NA | 0.456 | 10 | 14 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
Source | Year | Carriers | Unaffected | LQT3 | BrS1 | Other | Other Disease |
---|---|---|---|---|---|---|---|
Literature, cohort, and gnomAD | – | 0 | 0 | 0 | 0 | – | |
Variant features alone | – | 15 | 14 | 0 | 1 | – | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
Neighbour residue | Distance (Å) | Observed variants |
---|---|---|
413 | 15 | A413T, A413E, |
414 | 14 | M414V, |
415 | 14 | A415T, |
416 | 13 | Y416C, |
417 | 13 | |
418 | 12 | E418K, |
419 | 11 | Q419X, |
420 | 11 | |
421 | 10 | |
422 | 9 | |
423 | 8 | |
424 | 8 | I424M, |
425 | 7 | A425T, A425P |
426 | 5 | |
427 | 4 | |
428 | 0 | E428K, |
429 | 4 | E429K, p.E429del, |
430 | 5 | K430E, |
431 | 7 | |
432 | 8 | |
433 | 8 | R433C, R433H, R433S, |
434 | 9 | |
435 | 10 | |
436 | 11 | |
437 | 11 | A437V, |
438 | 12 | M438L, M438T, M438L, |
439 | 13 | E439V, E439K, |
440 | 13 | |
441 | 14 | L441F, |
442 | 14 | |
443 | 15 |